The Canadian Cancer Society–Cancer Research UK Biology to Prevention Award 2026 supports collaborative UK–Canada research translating biological discoveries into new approaches to prevent cancer. Funding includes up to £600,000 for UK research and C$1 million for Canadian research, over a maximum of five years.
Projects may investigate preventive drugs, dietary or immunological interventions, precancerous changes, or biomarkers predicting cancer development. Applicants must explain how their research could ultimately reduce cancer risk or incidence.
Eligibility Criteria
- Teams must include UK- and Canada-based lead applicants with a genuine intellectual partnership.
- UK applicants must be based at an eligible university, medical school, hospital or research institute.
- UK applicants must have postdoctoral experience or equivalent.
- Research must address primary cancer prevention through biological or mechanistic insights.
- Applicants must discuss their proposal with CRUK before receiving access to the application.
- Canadian applicants must obtain CCS approval of their budget and include the approved costing form.
- Host institutions must approve the application and provide appropriate research resources.
Funding Details
- UK component: Up to £600,000.
- Canadian component: Up to C$1 million in direct research costs.
- Duration: Up to five years.
Deadline
- Canadian budget submission: November 27, 2026, at 11:59 p.m. ET.
- Full application: December 4, 2026, submitted by the UK lead through Flexi-Grant.
- Initial CRUK discussion: Applicants should make contact at least one month before the full deadline.
- Funding results: Summer 2027.
- Expected funding start: Late summer 2027.